Glycopyrronium bromide (brand name Seebri Breezhaler) is an inhaled treatment for people with stable chronic obstructive pulmonary disease (COPD). It is a long-acting bronchodilator, and works by relaxing the airways in the lungs over about 24 hours, to make breathing easier.
When it comes to new medicines that are relevant to your condition, how do you decide if 'new' is 'better'? Medicine Update helps you to answer this question as new medicines become available.
Each issue includes an independent assessment of current information and research about a different medicine.
Find out more about Medicine Update.
- reliable, up-to-date information on health issues
- articles to help you make decisions about medicines and medical tests
- links to our resources and tools for managing your health
- the answer to one of the most commonly asked Medicinewise questions.